HJ
Hemang Jitendra Marfatia
About Hemang Jitendra Marfatia
Data last updated:
Hemang Jitendra Marfatia is a Director at Jashjit Pharmaceuticals Private Limited (since 2019). The companies operate in Business Services and Professional Services. Jashjit Pharmaceuticals Private Limited reported revenue of ₹3,202 (FY 2020). Earlier, Hemang Jitendra Marfatia was a Cfo at Sudarshan Pharma Industries Limited (2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Jashjit Pharmaceuticals Private Limited U74999MH2019PTC321357 | Director | 18 Feb 2019 | 2019 | ₹3,202 (FY 2020) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Sudarshan Pharma Industries Limited L51496MH2008PLC184997 | Cfo | 22 Jan 2019 | 2008 | ₹712 Cr (FY 2026) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Hemang Jitendra Marfatia
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nina Hemang Marfatia | 08365331 | Jashjit Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Hemang Jitendra Marfatia
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Hemang Jitendra Marfatia
Hemang Jitendra Marfatia currently holds 1 directorship: Jashjit Pharmaceuticals Private Limited (Director, since 18 Feb 2019, revenue ₹3,202 (FY 2020)).
Hemang Jitendra Marfatia was first appointed on 22 Jan 2019 as Cfo at Sudarshan Pharma Industries Limited.
Hemang Jitendra Marfatia held 1 earlier board appointment: Sudarshan Pharma Industries Limited (Cfo, 22 Jan 2019 to 13 Apr 2019).
The current boards of Hemang Jitendra Marfatia's companies include Nina Hemang Marfatia (Jashjit Pharmaceuticals Private Limited).